Social Cognition and Interaction Training for Improving Social Functioning in People With Schizophrenia

March 28, 2013 updated by: David Penn, PhD, University of North Carolina, Chapel Hill

Social Cognition and Interaction Training for Schizophrenia

This study will determine the effectiveness of social cognition and interaction training, a manual-based group therapy program, in helping people with schizophrenia improve their social cognition and social functioning.

Study Overview

Detailed Description

Schizophrenia is a serious mental condition that affects approximately 1.1% of adults in the United States. People with schizophrenia experience reality perception impairments, which most commonly manifest as hallucinations, extreme paranoia, social withdrawal, and disordered thinking. Deficits in social functioning are a core feature of schizophrenia. In an effort to improve social functioning, there has been growing interest in identifying factors that underlie psychosocial impairments. One such identified factor has been neurocognition, but treatments that target solely cognitive processes do not always help overall social functioning. Social cognition and interaction training (SCIT), a group-based treatment that aims to improve both processing social information and functioning, may be an effective treatment for enhancing the social skills of people with schizophrenia. This study will compare the effectiveness of SCIT versus treatment as usual (TAU) in helping people with schizophrenia improve their social cognition and social functioning.

Participation in this single-blind study will last 11 months. All potential participants will undergo initial screening, involving the completion of a few brief tasks testing social functioning. Eligible participants will then be randomly assigned to receive SCIT plus TAU or TAU alone. Participants assigned to receive SCIT will attend twenty 1-hour weekly group sessions over 5 months. During these sessions, participants will learn ways to manage emotions, work through problems, and integrate into social situations. Participants assigned to TAU alone will meet with their case managers and healthcare provider on an as-needed basis. All participants will undergo assessments of social cognition, social functioning, and psychotic symptoms prior to treatment, immediately post-treatment, and 6 months after treatment. Each assessment will last 3 hours and will include interviews, questionnaires, and a variety of tasks testing social skills. Researchers will also contact a family member or significant other about the participant's social functioning at the same three assessment times noted above.

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Chapel Hill, North Carolina, United States, 27599
        • University of North Carolina Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 61 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Meets DSM-IV criteria for schizophrenia or schizoaffective disorder, based on the Structured Interview of DSM-IV patient version (SCID-P)

Exclusion Criteria:

  • Meets current criteria for substance dependence, based on the SCID-P
  • Meets criteria for metal retardation (e.g., has an IQ of less than 80)
  • History of brain injuries
  • Difficulties interacting with others, based on ratings on items from the Social Functioning Scale that tap interactional skills

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 2
Participants will receive treatment as usual
TAU will involve routine care and meeting with case-managers and healthcare providers on an as-needed basis.
Experimental: 1
Participants will receive social cognition and interaction training plus treatment as usual
SCIT is a group-based treatment that has the goal of improving social cognition and social functioning for individuals with psychotic disorders. SCIT is composed of three phases: emotion training, figuring out situations, and integration. SCIT will be delivered by two therapists in 20 weekly sessions over 5 months.
TAU will involve routine care and meeting with case-managers and healthcare providers on an as-needed basis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Face Emotion Identification Task (FEIT)
Time Frame: Measured at baseline, post-treatment, and 6-month follow-up
Measured at baseline, post-treatment, and 6-month follow-up
Face Emotion Discrimination Task (FEDT)
Time Frame: Measured at baseline, post-treatment, and 6-month follow-up
Measured at baseline, post-treatment, and 6-month follow-up
The Hinting Task
Time Frame: Measured at baseline, post-treatment, and 6-month follow-up
Measured at baseline, post-treatment, and 6-month follow-up
The Awareness of Social Inference Test (TASIT)
Time Frame: Measured at baseline, post-treatment, and 6-month follow-up
Measured at baseline, post-treatment, and 6-month follow-up
Ambiguous Intentions Hostility Questionnaire(AIHQ)
Time Frame: Measured at baseline, post-treatment, and 6-month follow-up
Measured at baseline, post-treatment, and 6-month follow-up

Secondary Outcome Measures

Outcome Measure
Time Frame
"Beads in the Jar" Task
Time Frame: Measured at baseline, post-treatment, and 6-month follow-up
Measured at baseline, post-treatment, and 6-month follow-up
Quality of Life Scale (QLS)
Time Frame: Measured at baseline, post-treatment, and 6-month follow-up
Measured at baseline, post-treatment, and 6-month follow-up
Positive and Negative Syndrome Scale (PANSS)
Time Frame: Measured at baseline, post-treatment, and 6-month follow-up
Measured at baseline, post-treatment, and 6-month follow-up
Social Skills Performance Assessment (SSPA)
Time Frame: Measured at baseline, post-treatment, and 6-month follow-up
Measured at baseline, post-treatment, and 6-month follow-up
Schizophrenia Cognition Rating Scale (SCoRS)
Time Frame: Measured at baseline, post-treatment, and 6-month follow-up
Measured at baseline, post-treatment, and 6-month follow-up
Overt Social Cognition: A Rating Scale (OSCARS)
Time Frame: Measured at baseline, post-treatment, and 6-month follow-up
Measured at baseline, post-treatment, and 6-month follow-up
Lecomte Self-Esteem Scale
Time Frame: Measured at baseline, post-treatment, and 6-month follow-up
Measured at baseline, post-treatment, and 6-month follow-up
Number of Hospital Admissions
Time Frame: Measured at baseline, post-treatment, and 6-month follow-up
Measured at baseline, post-treatment, and 6-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David L. Penn, PhD, University of North Carolina, Chapel Hill

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2007

Primary Completion (Actual)

July 1, 2010

Study Completion (Actual)

July 1, 2010

Study Registration Dates

First Submitted

January 15, 2008

First Submitted That Met QC Criteria

January 15, 2008

First Posted (Estimate)

January 28, 2008

Study Record Updates

Last Update Posted (Estimate)

March 29, 2013

Last Update Submitted That Met QC Criteria

March 28, 2013

Last Verified

March 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • R34MH080010 (U.S. NIH Grant/Contract)
  • DATR A2-AISZ (World Health Organization ICTRP)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia

Clinical Trials on Social cognition and interaction training (SCIT)

Subscribe